Medical Device & Life Sciences Commercial Strategy
We help medical device and life sciences companies do more than win the next bid — we build the RFP strategy, GPO/IDN/health system contracting, and the CRM discipline and analytics that keep growth from slipping through the cracks.
Proven Growth
$4M → $96M
Revenue scaled at a global orthobiologics company through IPO
$4M → $45M
Revenue scaled at a specialty life science company ahead of acquisition
GPO
Sole Awardee
National spine hardware GPO contract
IDN
Sole Awardee
National pediatric-focused IDN contract
What We Do
Launch and Growth Strategy
The commercial plan behind a new product launch or a push into the next revenue tier — sequencing, coverage, and the milestones that keep growth from stalling out.
National Account Strategy
Account segmentation, tiering, and coverage models that turn a signed contract into realized share.
Go-to-Market Pricing
Pricing architecture built for the reimbursement and procurement environment you're actually selling into — not a spreadsheet exercise.
GPO / IDN Contracting
National and regional contracting strategy for GPOs and integrated delivery networks — from first submission through renewal and compliance.
RFP Strategy
We build the response before the RFP drops — positioning, pricing, and proof points aligned to what the committee is actually scoring.
VAC Submissions
Value Analysis Committee packages built to survive the room — including the symplr Value Analysis hurdle most submissions stall on — with clinical evidence, budget impact, and objection-handling built in from the first draft.
Sectors We Serve
Nick Navarro
Founder, Aspen Maxwell Consulting
Nick Navarro is the founder of Aspen Maxwell Consulting, partnering with emerging medical device companies on RFP strategy, Value Analysis Committee submissions (including Lumere), GPO/IDN contracting, and go-to-market pricing. He brings 15+ years of progressive commercial leadership — rising from VP of Global Sales to, most recently, Director of Commercial Excellence at a large spinal implant company — driving aggressive revenue growth across biologics, surgical implants, and medical device ventures with a business-owner mindset.
Along the way he's built high-performance sales organizations from scratch, scaled one orthobiologics company from $4M to $96M through IPO, helped scale another specialty life science company from $4M to $45M ahead of its acquisition, and led complex hospital, IDN, and GPO contract negotiations to sole-awardee status on national contracts other bidders couldn't crack. A multi-time President's Club honoree, he's quick to credit the admired leaders and mentors who shaped him along the way — the kind of guidance that, over 15+ years, turned a strong performer into a force all his own.
He's recognized for clinical credibility and the ability to build trusted relationships with surgeons, clinical decision-makers, and hospital executives across hip, knee, foot & ankle, spine, and orthobiologics categories — and as a collaborative leader skilled in cross-functional alignment, talent development, and driving accountability in fast-paced, competitive environments.
Aspen Maxwell Consulting exists to bring that same playbook to companies that don't have 15 years to learn it themselves — domestic manufacturers launching new products or expanding their current portfolio, and international companies trying to get real traction in the US market for the first time. Whether you are a brand-new startup bringing a product to market, or an established business looking to scale to the next level, we will meet you where you are and help you get to where you want to be.
Trust isn't a tagline. It's a track record.
Areas of Expertise
Access · Growth · Leverage
Flexible pricing structures available. Request a free consultation for a custom quote.